等待开盘 02-03 09:30:00 美东时间
+8.580
+1.76%
今日重点评级关注:HC Wainwright & Co.:维持Praxis Precision Medicine"买入"评级,目标价从340美元升至1245美元;HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从10美元升至12美元
02-02 14:15
今日重点评级关注:Piper Sandler:维持Praxis Precision Medicine"超配"评级,目标价从450美元升至1200美元;Tigress Financial:维持Main International ETF"买入"评级,目标价从52美元升至66美元
01-29 11:06
U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth Jan 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Boeing, Carvana and UnitedHealth on Wednesday. HIGHLIGHTS * Boeing BA.N : JP Morgan raises target price to $270
01-28 15:23
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据HCA Healthcare业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **2025年第四季度表现:** - 营收同比增长6.7%,反映持续需求和网络扩张 - 归属于HCA Healthcare的净利润同比增长近31% - 调整后每股收益同比增长29% - 调整后EBITDA同比增长约11%,其中飓风影响市场贡献约1.5亿美元 - 调整后EBITDA利润率环比和同比均有改善,季度同比提升80个基点 **2025年全年表现:** - 同设施基础营收增长6.6% - 合并调整后EBITDA同比增长12.1% - 调整后EBITDA利润
01-28 12:35
BUZZ-U.S. STOCKS ON THE MOVE-Sysco, Corning, HCA Healthcare Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and Nasdaq advanced on Tuesday as investors parsed through a s
01-27 23:45
HCA Healthcare shares are trading higher after the company reported better-than...
01-27 22:10
BUZZ-U.S. STOCKS ON THE MOVE-RTX, Kimberly-Clark, HCA Healthcare Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq were set to open higher on Tuesday as inve
01-27 22:06
华盛资讯1月27日讯,HCA控股公布2025财年Q4业绩,公司Q4营收195.13亿美元,同比增长6.7%,归母净利润18.78亿美元,同比增长30.6%。
01-27 21:31
HCA Healthcare's Q4 revenue slightly misses estimates, announces buyback Overview Healthcare provider's Q4 revenue rose 6.7% yr/yr, slightly missing analyst expectations Net income for Q4 increased 30.6% yr/yr, driven by facility sales gains Company announced $10 bln share repurchase program Outlook
01-27 20:09
HCA Healthcare (NYSE:HCA) raises FY2025 GAAP EPS guidance from $27.00-$28.00 to $29.10-$31.50 vs $27.46 analyst estimate. Raises FY2025 sales outlook from $75.000 billion-$76.500 billion to $76.500 billion-$80.000
01-27 20:03